Trials / Completed
CompletedNCT00560781
Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Durham VA Medical Center · Federal
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will test the therapeutic potential of augmenting a stable SSRI regimen with the neurosteroid pregnenolone to reduce cognitive symptoms and PTSD symptoms in patients diagnosed with PTSD.
Detailed description
See brief summary
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregnenolone or Placebo | Pregnenolone 50 mg BID, Pregnenolone 150 mg BID, Pregnenolone 250 mg BID |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2007-04-01
- Completion
- 2007-05-01
- First posted
- 2007-11-20
- Last updated
- 2014-02-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00560781. Inclusion in this directory is not an endorsement.